SILICOS™ discovery process
IP: the molecules are proprietary, all patents applicable
EFFICACY: size of molecular library (efficacy found superior when the number of screened candidates is high (100 000 molecules)
SUSTAINABILITY: no destruction of material
COST AND DURATION: the virtual screening is quick and low cost
SCIENCE: efficacy/structure elucidation
REGULATORY, TOXICOLOGY: the molecule is well defined; the screening may include constraints such as nature of aminoacids, structure of the molecule to meet certain requirements.